News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
483,102 Results
Type
Article (8020)
Company Profile (139)
Press Release (474847)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166781)
Career Advice (306)
Deals (25744)
Drug Delivery (7)
Drug Development (52882)
Employer Resources (14)
FDA (9763)
Job Trends (8579)
News (238268)
Policy (17933)
Tag
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (481)
Accelerated approval (21)
ADA (18)
Adcomms (1)
Allergies (94)
Alliances (33163)
ALS (102)
Alzheimer's disease (965)
Antibody-drug conjugate (ADC) (253)
Approvals (10332)
Artificial intelligence (307)
ASCO (159)
Autoimmune disease (194)
Automation (27)
Bankruptcy (262)
Best Places to Work (6964)
BIO (36)
BIOSECURE Act (1)
Biosimilars (103)
Biotechnology (88)
Bladder cancer (132)
Brain cancer (28)
Breast cancer (498)
Cancer (3544)
Cardiovascular disease (213)
Career advice (246)
Career pathing (1)
CAR-T (166)
Celiac Disease (1)
Cell therapy (463)
Cervical cancer (34)
Clinical research (47720)
Collaboration (1196)
Compensation (1386)
Complete response letters (33)
COVID-19 (751)
CRISPR (62)
C-suite (700)
Cystic fibrosis (84)
Data (5482)
Denatured (4)
Depression (101)
Dermatology (59)
Diabetes (332)
Diagnostics (4140)
Digital health (36)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (144)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (157)
Earnings (72995)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87433)
Executive appointments (678)
FDA (12270)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (16)
Frontotemporal dementia (23)
Funding (886)
Gene editing (123)
Generative AI (9)
Gene therapy (307)
GLP-1 (284)
Government (948)
Grass and pollen (2)
Guidances (278)
Healthcare (9320)
Hematology (94)
HIV (49)
Huntington's disease (22)
IgA nephropathy (60)
Immunology and inflammation (95)
Immuno-oncology (54)
Indications (149)
Infectious disease (936)
Inflammatory bowel disease (125)
Inflation Reduction Act (4)
Influenza (83)
Intellectual property (246)
Interviews (42)
IPO (12380)
IRA (2)
Job creations (1969)
Job search strategy (235)
JPM (1)
Kidney cancer (14)
Layoffs (59)
Legal (5209)
Liver cancer (43)
Longevity (15)
Lung cancer (487)
Lymphoma (240)
Machine learning (27)
Management (3)
Manufacturing (506)
Marketing (6)
MASH (115)
Medical device (8646)
Medtech (8763)
Mergers & acquisitions (14349)
Metabolic disorders (685)
mRNA (50)
Multiple sclerosis (100)
NASH (4)
Neurodegenerative disease (209)
Neuropsychiatric disorders (38)
Neuroscience (1775)
NextGen: Class of 2026 (3153)
Non-profit (846)
Obesity (219)
Opinion (10)
Ovarian cancer (155)
Pain (167)
Pancreatic cancer (190)
Parkinson's disease (195)
Partnered (11)
Patents (455)
Patient recruitment (473)
Peanut (31)
People (41130)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15427)
Phase 2 (21307)
Phase 3 (14348)
Pipeline (6601)
Policy (18)
Postmarket research (1572)
Preclinical (6524)
Press Release (34)
Prostate cancer (185)
Psychedelics (7)
Radiopharmaceuticals (187)
Rare diseases (552)
Real estate (3022)
Recruiting (6)
Regulatory (14667)
Reports (16)
Research institute (579)
Resumes & cover letters (46)
Rett syndrome (39)
RNA editing (5)
RSV (47)
Schizophrenia (97)
Series A (147)
Series B (116)
Service/supplier (4)
Sickle cell disease (61)
Spinal muscular atrophy (87)
Sponsored (5)
Startups (2019)
Stomach cancer (3)
Supply chain (47)
Vaccines (310)
Venture capital (17)
Weight loss (69)
Women's health (73)
Date
Today (45)
Last 7 days (261)
Last 30 days (1070)
Last 365 days (19092)
2026 (10558)
2025 (19252)
2024 (22985)
2023 (26549)
2022 (34592)
2021 (37176)
2020 (33488)
2019 (23261)
2018 (17494)
2017 (18772)
2016 (17920)
2015 (24265)
2014 (21684)
2013 (18140)
2012 (20228)
2011 (20449)
2010 (20336)
Location
Africa (227)
Alabama (68)
Alaska (2)
Arizona (290)
Arkansas (11)
Asia (17828)
Australia (2088)
California (11464)
Canada (3037)
China (499)
Colorado (462)
Connecticut (388)
Delaware (201)
Europe (24590)
Florida (1708)
Georgia (363)
Hawaii (2)
Idaho (46)
Illinois (675)
India (40)
Indiana (308)
Iowa (13)
Japan (383)
Kansas (98)
Kentucky (30)
Louisiana (24)
Maine (25)
Maryland (1146)
Massachusetts (7558)
Michigan (299)
Minnesota (535)
Mississippi (4)
Missouri (76)
Montana (20)
Nebraska (11)
Nevada (112)
New Hampshire (60)
New Jersey (2526)
New Mexico (11)
New York (2724)
North Carolina (1222)
North Dakota (4)
Northern California (5699)
Ohio (263)
Oklahoma (14)
Oregon (14)
Pennsylvania (2185)
Puerto Rico (20)
Rhode Island (29)
South America (406)
South Carolina (75)
South Dakota (1)
Southern California (4757)
Tennessee (113)
Texas (1847)
United States (37315)
Utah (342)
Vermont (1)
Virginia (144)
Washington D.C. (39)
Washington State (890)
West Virginia (1)
Wisconsin (71)
483,102 Results for "nexeon medsystems inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Channel Medsystems Appoints Robert Brown, MBA, CPA, as Chief Financial Officer
November 21, 2025
·
2 min read
Deals
Boston Scientific Closes Acquisition of Relievant Medsystems, Inc.
Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Relievant Medsystems Inc.
November 17, 2023
·
5 min read
Press Releases
FemDx Medsystems Announces Successful First-in-Human Study
April 29, 2025
·
2 min read
Deals
Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc.
Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Relievant Medsystems, Inc., a privately held medical technology company.
September 19, 2023
·
6 min read
Biotech Bay
Credence MedSystems Announces a Significant Milestone Towards Scaling Manufacturing Capabilities
Credence MedSystems announced that it has successfully completed Factory Acceptance Testing for production of its Companion® injection device platform on the Company’s new Clinical Assembly Line.
January 18, 2024
·
3 min read
Biotech Bay
FemDx Medsystems, Inc. Receives FDA Clearance For Its FalloView™ Falloposcope
FemDx Medsystems, Inc., a women’s health startup based in Santa Clara, CA announces the company has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its FalloView™ device.
March 27, 2023
·
1 min read
Relievant Medsystems Introduces Next-Generation Access Instruments to Advance Intracept Procedure for Chronic Vertebrogenic Low Back Pain
Relievant Medsystems today announced the release of next-generation Intracept ® Access Instruments.
July 14, 2023
·
3 min read
BioMidwest
Relievant Medsystems Announces Positive Coverage Policy for the Intracept Procedure from Anthem Blue Cross and Blue Shield
Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic low back pain, announced that Anthem Blue Cross and Blue Shield has established favorable coverage for the Intracept® Procedure.
October 3, 2023
·
3 min read
BioMidwest
Relievant Medsystems Announces Pooled 4-Year Outcomes Validating Long-Term Effectiveness of the Intracept Procedure
Relievant Medsystems announced the presentation of four-year pooled results from two prospective clinical trials that further demonstrate the safety, effectiveness and long-term durability of the Intracept® Procedure for patients with vertebrogenic pain.
July 20, 2023
·
3 min read
BioMidwest
Relievant Medsystems Announces Pooled Analysis Demonstrating the Intracept Procedure Significantly Reduces Low Back Pain-related Healthcare Utilization
Relievant Medsystems announced the publication of a pooled analysis from three prospective clinical trials that demonstrates the impact of the company’s Intracept® Procedure on significantly reducing the long-term utilization of additional treatments for low back pain.
September 12, 2023
·
4 min read
1 of 48,311
Next
